Watson Recalls Necon 10/11 Tablets Due to Potential HCTZ Contamination
Watson Laboratories is recalling specific lots of Necon 10/11 oral contraceptives because they may contain trace amounts of Hydrochlorothiazide (HCTZ).
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score (4) under the rubric, as it involves a potential contamination with an unintended active ingredient.
Plain-English summary
Watson Laboratories, Inc. is recalling 1,684 cartons of Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP. The affected product is packaged in 28-count dispensers, with 6 dispensers per carton, and is distributed nationwide and in Puerto Rico. The specific lot number is 512642B, with an expiration date of 08/31/13.
The recall was initiated because certain lots of Necon 10/11, along with other products including Zovia, Lutera, and Zenchent, could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ). This cross-contamination occurred during the manufacturing process.
Consumers and healthcare providers should check their medication for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be returned to the pharmacy or point of purchase for disposal or replacement. Patients should consult their healthcare provider for guidance on alternative contraceptive options if they are using the affected product.
The recalled product
- Product
- Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/35 mcg, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson
- Manufacturer
- Watson Laboratories Inc
- Category
- Drug — Oral Contraceptive
- Affected units
- 1,684
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 512642B
- Exp 08/31/13
Distribution
Part of a larger recall action
This product is one of 5 recalled by Watson Laboratories Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Watson Laboratories Inc
See all →- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
- SevereWatson Recalls Carisoprodol Tablets Due to Metal Particulates
FDA (Drugs) · 2014-01-15
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- LowWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals
FDA (Drugs) · 2013-09-25
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27